JBM (Healthcare) Limited (HKG:2161)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.920
0.00 (0.00%)
Jul 31, 2026, 3:30 PM HKT

JBM (Healthcare) Cash Flow Statement

Millions HKD. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
201.09197.26130.4657.0924.62
Depreciation & Amortization
49.7452.2846.5243.6347.78
Loss (Gain) From Sale of Assets
0.610.120.010.130.01
Asset Writedown & Restructuring Costs
----2.5
Loss (Gain) From Sale of Investments
0.02-1.02--8.9-
Loss (Gain) on Equity Investments
-0.05-0.07-3.651.931.79
Stock-Based Compensation
18.425.629.030.25-
Other Operating Activities
163.3821.6116.27-4.43
Change in Accounts Receivable
-119.35-20.4-11.7318.65-3.21
Change in Inventory
6.289.34-37.02-6.690.14
Change in Accounts Payable
-10.36-19.5835.9923.25-9.21
Operating Cash Flow
162.4226.94191.22145.6260
Operating Cash Flow Growth
-28.44%18.68%31.31%142.71%2.11%

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-33.3-21.01-10.21-8.13-7.06
Sale of Property, Plant & Equipment
--0.160.04-
Cash Acquisitions
-126.82-102.6-1.86-
Investment in Securities
-1.5617.6-0.82-0.51
Other Investing Activities
0.81.570.760.270.02
Investing Cash Flow
-159.33-120.488.31-6.78-7.55

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Long-Term Debt Issued
538.17279.864240-
Total Debt Issued
538.17279.864240-
Long-Term Debt Repaid
-343.72-260.65-117.19-277.25-69.49
Total Debt Repaid
-343.72-260.65-117.19-277.25-69.49
Net Debt Issued (Repaid)
194.4519.15-53.19-37.25-69.49
Repurchase of Common Stock
-0.79-22.4-95.36-5.35-
Common Dividends Paid
-173.8-78.7-52.71-4.47-
Other Financing Activities
-109.1140.41-9.46-8.97-7.37
Financing Cash Flow
-89.26-41.54-210.72-56.04-76.85

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Foreign Exchange Rate Adjustments
0.270.13-0.26-0.37-0.13
Net Cash Flow
-85.9165.04-11.4682.42-24.53

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
129.1205.92181137.4852.94
Free Cash Flow Growth
-37.31%13.77%31.65%159.71%47.88%
Free Cash Flow Margin
15.47%26.32%27.91%26.42%13.03%
Free Cash Flow Per Share
0.160.250.200.150.06
Levered Free Cash Flow
101.04141.65155.92131.6848.75
Unlevered Free Cash Flow
108.34144.44161.23136.8152.75

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
11.694.468.58.216.41
Cash Income Tax Paid
45.9643.9220.5611.4716.95
Change in Working Capital
-123.43-30.64-12.7635.21-12.28